Cargando…

The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect?

Detalles Bibliográficos
Autores principales:	Maoujoud, Omar, Ahid, Samir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. on behalf of ISPOR--The professional society for health economics and outcomes research. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275977/ https://www.ncbi.nlm.nih.gov/pubmed/32688006 http://dx.doi.org/10.1016/j.vhri.2020.05.001

Ejemplares similares

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
por: Maoujoud, Omar, et al.
Publicado: (2016)

Stresses and anxieties in the time of the COVID-19 pandemic — what we can learn
por: Ayyala, Rama S., et al.
Publicado: (2020)

Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
por: Jacobs, Jeffrey P., et al.
Publicado: (2022)

Commentary: What has the coronavirus disease 2019 (COVID-19) pandemic really taught us?
por: Wang, Hanghang, et al.
Publicado: (2021)

The impact of social networking services on the coronavirus disease 2019 (COVID-19) pandemic in sub-Saharan Africa
por: Endomba, Francky Teddy, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
por: Husain-Syed, Faeq, et al.
Publicado: (2021)

Commentary: Can we do better during a potential second wave of coronavirus disease 2019 (COVID-19)?
por: Engelman, Daniel T., et al.
Publicado: (2020)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

The Cost-Effectiveness of Continuous Erythropoiesis Receptor Activator Once Monthly versus Epoetin Thrice Weekly for Anaemia Management in Chronic Haemodialysis Patients
por: Maoujoud, Omar, et al.
Publicado: (2015)

What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?
por: Chen, Yusha, et al.
Publicado: (2020)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

What will we choose to learn from the COVID-19 pandemic?
por: Bayingana, Alice Uwase, et al.
Publicado: (2021)

PTSD symptoms in healthcare workers facing the three coronavirus outbreaks: What can we expect after the COVID-19 pandemic
por: Carmassi, Claudia, et al.
Publicado: (2020)

Looking Back on 2019 in Rheumatology and What to Expect from 2020
por: Fleischmann, Roy
Publicado: (2019)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

The COVID-19 pandemic in the USA: what might we expect?
por: Chowell, Gerardo, et al.
Publicado: (2020)

Poverty, protests and pandemics: what can we learn from community resilience?
por: Ahmed, Rashid, et al.
Publicado: (2021)

Commentary: Coronavirus disease 2019 (COVID-19) and the airway: How can surgery help?
por: Rendina, Erino Angelo, et al.
Publicado: (2020)

Modelling Covid-19 under uncertainty: what can we expect?
por: Wang, Meimei, et al.
Publicado: (2020)

Lung cancer in the era of COVID-19: what can we expect?
por: Araujo-Filho, Jose de Arimateia Batista, et al.
Publicado: (2020)

The male disadvantage in life expectancy: can we close the gender gap?
por: Hossin, Muhammad Zakir
Publicado: (2021)

COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?
por: Freudenberg, Lutz S., et al.
Publicado: (2022)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

The COVID-19 pandemic death toll in India: can we know better?
por: Gupta, M, et al.
Publicado: (2023)

What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
por: McKee, Martin, et al.
Publicado: (2021)

Clinical trials for coronavirus disease 2019: What is being evaluated and what is not
por: Arabi, Yaseen M., et al.
Publicado: (2020)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Commentary: Performing cardiac surgery in the coronavirus disease 2019 (COVID-19) era: What is the new normal?
por: Mohammadi, Siamak, et al.
Publicado: (2020)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

Building capacity for integrated knowledge translation: a description of what we can learn from trainees’ experiences during the COVID-19 pandemic
por: Medeiros, Priscilla, et al.
Publicado: (2022)

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
por: Barzegar, Mahdi, et al.
Publicado: (2021)

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
por: Sedaghat, Nahad
Publicado: (2021)

Politics of citizenship during the COVID-19 pandemic: what can educators do?
por: Arshad-Ayaz, Adeela, et al.
Publicado: (2021)

What Can COVID-19 Teach Us about Using AI in Pandemics?
por: Laudanski, Krzysztof, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19): What we need to know
por: Javanian, Mostafa, et al.
Publicado: (2020)

Suicide epidemic in Malawi: what can we do?
por: Banda, Gift Treighcy, et al.
Publicado: (2021)

Commentary: Adapting the practice of congenital heart surgery to the coronavirus disease 2019 (COVID-19) pandemic
por: Bacha, Emile
Publicado: (2021)

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt
por: Villani, Alessia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jfibu6jpnqnaa26npkepbchqp6